<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03541330</url>
  </required_header>
  <id_info>
    <org_study_id>2016_83</org_study_id>
    <secondary_id>2016-A02091-50</secondary_id>
    <nct_id>NCT03541330</nct_id>
  </id_info>
  <brief_title>Information and Accompaniment of Siblings Following the Announcement of a Cancer in Pediatric Hematology.</brief_title>
  <official_title>Information and Accompaniment of Siblings Following the Announcement of a Cancer in Pediatric Hematology.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is to evaluate the experience with the information received on the
      disease by the healthy brothers and sisters of childrens with malignant haemopathy at the
      Centre Hospitalier Régional et Universitaire of Lille
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 22, 2018</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Level of satisfaction and characteristics of information received about the disease by healthy siblings of children with hematological malignancies</measure>
    <time_frame>1 year</time_frame>
    <description>Measure Qualitative Interviews by Grounded theory. The experience with the information received on the disease by the healthy brothers and sisters of childrens with malignant haemopathy.
Assessment of the level of satisfaction with the information received. The information will be characterized according to three dimensions: the framework (by whom, with whom, where, when, how) and the content of the information</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Explore the representations of the disease in healthy siblings</measure>
    <time_frame>1 year</time_frame>
    <description>The representation of the disease is the set of personal beliefs of an individual about the disease. It allows him to make sense of the disease. These data will be analyzed during the semi-structured interview</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate their information and support needs following the announcement of the disease</measure>
    <time_frame>1 year</time_frame>
    <description>information and support needs gathered during the semi-structured interview</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Identify the possible psychic and social consequences of the disease in these healthy subjects</measure>
    <time_frame>1 year</time_frame>
    <description>to identify during the semi-directive interview the elements informing about the social behavior and the psychic state of the subject included, expressed spontaneously by the subject, directly (in the speech, for example &quot;I am sad&quot;) or indirectly (by attitude, for example: crying)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">23</enrollment>
  <condition>Malignant Haemopathy</condition>
  <arm_group>
    <arm_group_label>siblings</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Brother or sister of a child has malignant haemopathy and follow-up in the pediatric hematology department</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>semi-directive interview</intervention_name>
    <description>semi-structured interview conducted by a clinical psychologist</description>
    <arm_group_label>siblings</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children from 6 to 12 years old

          -  Brother or sister of a child:

        O has malignant haemopathy O follow-up in the pediatric hematology department in Lille, O
        diagnosed from 6 weeks to 1 year before maintenance of the healthy subject included

          -  whose parents are able to understand and sign voluntarily informed consent

          -  Affiliated to a social security scheme

          -  Ability to understand and answer questions alone during the semi-structured interview

        Exclusion Criteria:

          -  Child under 6 years or over 12 years

          -  Subject with a pathology that may interfere with the course of the study, according to
             the investigator's assessment

          -  Absence of the informed consent of one of the parents and / or the legal
             representative

          -  Refusal of participation of the subject
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eva De Berranger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eva De Berranger, MD</last_name>
    <phone>+33 3 20 44 46 62</phone>
    <phone_ext>+33</phone_ext>
    <email>eva.deberranger@chru-lille.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Jeanne de Flandres, CHU</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Eva De Berranger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 8, 2017</study_first_submitted>
  <study_first_submitted_qc>May 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2018</study_first_posted>
  <last_update_submitted>March 25, 2020</last_update_submitted>
  <last_update_submitted_qc>March 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Siblings</keyword>
  <keyword>information</keyword>
  <keyword>malignant haemopathy</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

